• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

miR-542-3p 通过靶向 BMP-7 控制肝星状细胞活化和纤维化。

MiR-542-3p controls hepatic stellate cell activation and fibrosis via targeting BMP-7.

机构信息

Department of Gastroenterology, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China.

Department of Gastroenterology, Affiliated Taizhou Hospital of Wenzhou Medical University, Taizhou, China.

出版信息

J Cell Biochem. 2019 Mar;120(3):4573-4581. doi: 10.1002/jcb.27746. Epub 2018 Oct 28.

DOI:10.1002/jcb.27746
PMID:30368874
Abstract

There has been an increasing number of studies about microRNAs as key regulators in the development of hepatic fibrosis. Here, we demonstrate that miR-542-3p can promote hepatic fibrosis by downregulating the expression of bone morphogenetic protein 7 (BMP-7), which is known to antagonize transforming growth factor β1 (TGFβ1)-mediated fibrogenesis effect. The expression of miR-542-3p is increased in activated hepatic stellate cells (HSCs). Downregulation of MiR-542-3p by antisense inhibitors can inhibit HSCs activation markers, including α-smooth muscle actin (α-SMA) and collagen as well as TGFβ signaling pathways. MiR-542-3p was significantly upregulated in carbon tetrachloride (CCl )-induced hepatic fibrosis in mice, and downregulation of miR-542-3p by lentivirus could prevent the development of hepatic fibrosis. In addition, miR-542-3p can directly bind to the 3'-untranslated region of BMP-7 mRNA, indicating that its profibrotic effect appears to be caused by its inhibition of BMP-7. Our results suggest that downregulation of miR-542-3p prevents liver fibrosis both in vitro and in vivo, highlighting its potential as a novel biomarker or therapeutic target for hepatic fibrosis.

摘要

越来越多的研究表明 microRNAs 是肝纤维化发展的关键调节因子。在这里,我们证明 miR-542-3p 可以通过下调骨形态发生蛋白 7(BMP-7)的表达来促进肝纤维化,BMP-7 已知拮抗转化生长因子 β1(TGFβ1)介导的纤维生成作用。miR-542-3p 在活化的肝星状细胞(HSCs)中的表达增加。反义抑制剂下调 miR-542-3p 可以抑制 HSCs 激活标志物,包括α-平滑肌肌动蛋白(α-SMA)和胶原以及 TGFβ 信号通路。miR-542-3p 在小鼠四氯化碳(CCl)诱导的肝纤维化中显著上调,通过慢病毒下调 miR-542-3p 可以预防肝纤维化的发展。此外,miR-542-3p 可以直接结合 BMP-7 mRNA 的 3'-非翻译区,表明其促纤维化作用似乎是由其对 BMP-7 的抑制引起的。我们的研究结果表明,下调 miR-542-3p 可预防体外和体内肝纤维化,突出了其作为肝纤维化新的生物标志物或治疗靶标的潜力。

相似文献

1
MiR-542-3p controls hepatic stellate cell activation and fibrosis via targeting BMP-7.miR-542-3p 通过靶向 BMP-7 控制肝星状细胞活化和纤维化。
J Cell Biochem. 2019 Mar;120(3):4573-4581. doi: 10.1002/jcb.27746. Epub 2018 Oct 28.
2
MicroRNA-101 suppresses liver fibrosis by targeting the TGFβ signalling pathway.MicroRNA-101 通过靶向 TGFβ 信号通路抑制肝纤维化。
J Pathol. 2014 Sep;234(1):46-59. doi: 10.1002/path.4373. Epub 2014 Jun 17.
3
miR-140-3p Knockdown Suppresses Cell Proliferation and Fibrogenesis in Hepatic Stellate Cells via PTEN-Mediated AKT/mTOR Signaling.miR-140-3p基因敲低通过PTEN介导的AKT/mTOR信号通路抑制肝星状细胞的增殖和纤维化。
Yonsei Med J. 2019 Jun;60(6):561-569. doi: 10.3349/ymj.2019.60.6.561.
4
Activation of Hepatic Stellate Cells is Inhibited by microRNA-378a-3p via Wnt10a.微小RNA-378a-3p通过Wnt10a抑制肝星状细胞的激活。
Cell Physiol Biochem. 2016;39(6):2409-2420. doi: 10.1159/000452509. Epub 2016 Nov 11.
5
MicroRNA-489-3p Represses Hepatic Stellate Cells Activation by Negatively Regulating the JAG1/Notch3 Signaling Pathway.miRNA-489-3p 通过负向调控 JAG1/Notch3 信号通路抑制肝星状细胞激活。
Dig Dis Sci. 2021 Jan;66(1):143-150. doi: 10.1007/s10620-020-06174-w. Epub 2020 Mar 7.
6
miR-193a/b-3p relieves hepatic fibrosis and restrains proliferation and activation of hepatic stellate cells.miR-193a/b-3p 缓解肝纤维化并抑制肝星状细胞的增殖和活化。
J Cell Mol Med. 2019 Jun;23(6):3824-3832. doi: 10.1111/jcmm.14210. Epub 2019 Apr 3.
7
MicroRNA-212 activates hepatic stellate cells and promotes liver fibrosis via targeting SMAD7.微小RNA-212通过靶向SMAD7激活肝星状细胞并促进肝纤维化。
Biochem Biophys Res Commun. 2018 Jan 29;496(1):176-183. doi: 10.1016/j.bbrc.2018.01.019. Epub 2018 Jan 4.
8
Bone morphogenetic protein-7 represses hepatic stellate cell activation and liver fibrosis regulation of TGF-β/Smad signaling pathway.骨形态发生蛋白-7 抑制肝星状细胞活化和肝纤维化——调节 TGF-β/Smad 信号通路。
World J Gastroenterol. 2019 Aug 14;25(30):4222-4234. doi: 10.3748/wjg.v25.i30.4222.
9
miR-29a-3p suppresses hepatic fibrosis pathogenesis by modulating hepatic stellate cell proliferation via targeting PIK3R3 gene expression.miR-29a-3p 通过靶向 PIK3R3 基因表达抑制肝星状细胞增殖从而抑制肝纤维化发病机制。
Biochem Biophys Res Commun. 2020 Sep 3;529(4):922-929. doi: 10.1016/j.bbrc.2020.06.102. Epub 2020 Jul 30.
10
Protective effect of Idelalisib on carbon tetrachloride-induced liver fibrosis via microRNA-124-3P/phosphatidylinositol-3-hydroxykinase signalling pathway.依鲁替尼通过 microRNA-124-3P/磷脂酰肌醇-3-羟激酶信号通路对四氯化碳诱导的肝纤维化的保护作用。
J Cell Mol Med. 2021 Dec;25(24):11185-11197. doi: 10.1111/jcmm.17039. Epub 2021 Nov 7.

引用本文的文献

1
Emerging Biomarker Potential of Extracellular Vesicle-Enclosed MicroRNAs for Liver Fibrosis Detection.细胞外囊泡包裹的微小RNA在肝纤维化检测中的新兴生物标志物潜力
Cells. 2025 Jul 4;14(13):1025. doi: 10.3390/cells14131025.
2
LncRNA GAS5 reduces blood glucose levels and alleviates renal fibrosis in diabetic nephropathy by regulating the miR-542-3p/ERBB4 axis.长链非编码RNA GAS5通过调控miR-542-3p/ERBB4轴降低糖尿病肾病患者的血糖水平并减轻肾纤维化。
Diabetol Metab Syndr. 2025 Jan 23;17(1):30. doi: 10.1186/s13098-025-01593-z.
3
circSIRT2/miR-542-3p/VASH1 axis regulates endothelial-to-mesenchymal transition (EndMT) in subretinal fibrosis in age-related macular degeneration models.
环SIRT2/miR-542-3p/VASH1轴在年龄相关性黄斑变性模型的视网膜下纤维化中调节内皮-间充质转化(EndMT)。
Aging Cell. 2025 Apr;24(4):e14443. doi: 10.1111/acel.14443. Epub 2025 Jan 2.
4
Noncoding RNA-Mediated Epigenetic Regulation in Hepatic Stellate Cells of Liver Fibrosis.非编码RNA介导的肝纤维化肝星状细胞中的表观遗传调控
Noncoding RNA. 2024 Aug 7;10(4):44. doi: 10.3390/ncrna10040044.
5
BMP7-Loaded Human Umbilical Cord Mesenchymal Stem Cell-Derived Small Extracellular Vesicles Ameliorate Liver Fibrosis by Targeting Activated Hepatic Stellate Cells.BMP7 负载的人脐带间充质干细胞来源的小细胞外囊泡通过靶向激活的肝星状细胞改善肝纤维化。
Int J Nanomedicine. 2024 Apr 11;19:3475-3495. doi: 10.2147/IJN.S450284. eCollection 2024.
6
Effects of Mesenchymal Stem Cells-Derived Extracellular Vesicles on Inhibition of Hepatic Fibrosis by Delivering miR-200a.间充质干细胞来源的细胞外囊泡通过递送 miR-200a 抑制肝纤维化的作用。
Tissue Eng Regen Med. 2024 Jun;21(4):609-624. doi: 10.1007/s13770-024-00631-7. Epub 2024 Apr 3.
7
Epigenetic modification in liver fibrosis: Promising therapeutic direction with significant challenges ahead.肝纤维化中的表观遗传修饰:充满希望的治疗方向,但前路挑战重重。
Acta Pharm Sin B. 2024 Mar;14(3):1009-1029. doi: 10.1016/j.apsb.2023.10.023. Epub 2023 Nov 4.
8
Multiomics endotyping of preterm infants with bronchopulmonary dysplasia and pulmonary hypertension-A pilot study.支气管肺发育不良和肺动脉高压早产儿的多组学内型分析——一项试点研究。
Pulm Circ. 2023 Apr 1;13(2):e12232. doi: 10.1002/pul2.12232. eCollection 2023 Apr.
9
Assessment of , , and Expression Profile and Regulatory miRNA-542-3p in Eutopic and Ectopic Endometrium of Women with Endometriosis.评估子宫内膜异位症患者在位和异位子宫内膜中 、 、 的表达谱及调控微小 RNA-542-3p。
Int J Mol Sci. 2023 Apr 2;24(7):6637. doi: 10.3390/ijms24076637.
10
Insights on drug and gene delivery systems in liver fibrosis.肝纤维化中药物和基因递送系统的见解
Asian J Pharm Sci. 2023 Mar;18(2):100779. doi: 10.1016/j.ajps.2023.100779. Epub 2023 Jan 29.